364 filings
Page 5 of 19
6-K
dal1 hg6kxldcjq2s
25 Nov 16
Rosetta Genomics Announces Pricing of $5 Million Concurrent
12:00am
6-K
owcx2e6qr
20 Oct 16
Rosetta Genomics Appoints Mark R. Willig as Chief Commercial Officer
12:00am
6-K
hcixugz
14 Oct 16
Current report (foreign)
12:00am
6-K
m6p2l1p
13 Oct 16
Current report (foreign)
12:00am
6-K
e0q11i0p4nswmnexro4b
26 Sep 16
Current report (foreign)
12:00am
6-K
g09870x6pymr egypby
22 Aug 16
Current report (foreign)
12:00am
6-K
eashdq s3tuliby6
9 Aug 16
Current report (foreign)
12:00am
6-K
kxtqo
1 Aug 16
Current report (foreign)
12:00am
6-K
wbbhz
24 Jun 16
Current report (foreign)
12:00am
6-K
skd7ryq1aw8 p3
21 Jun 16
Rosetta Genomics Receives Approval from New York State for HEME FISH-based Assays
12:00am
6-K
m3vpwu i4hsk
26 May 16
Current report (foreign)
12:00am
6-K
l2rbi5c
19 May 16
Rosetta Genomics Reports 2016 First Quarter Financial Results
12:00am
424B2
h61od
30 Mar 16
Prospectus for primary offering
12:00am
EFFECT
qzhpqkz
30 Mar 16
Notice of effectiveness
12:00am
CORRESP
cwt2yqx
28 Mar 16
Correspondence with SEC
12:00am
UPLOAD
gv5pq zye7ff8bruv15
28 Mar 16
Letter from SEC
12:00am
F-3
jcgzepw6
23 Mar 16
Shelf registration (foreign)
12:00am
6-K
qktj33z2
25 Feb 16
Rosetta Genomics Receives Approval from New York State for First-of-its-kind Thyroid Cancer Diagnostic Assay
12:00am
6-K
isjenr2rf0u4 3nk
6 Jan 16
Current report (foreign)
12:00am